BCL2L1 and leukemia: In U937 leukemia cells, bryostatin 1, in combination with cytarabine (ara-C), increased cytochrome c and Smac/DIABLO release, activation of caspases-3 and -9 and loss of the mitochondrial membrane potential, leading to apoptosis, even in cells overexpressing Bcl-xL.